12-week coffee compound study shows promising results for weight and fat reduction in at-risk individuals

Cafestol may aid in reducing body weight and visceral fat, but its impact on insulin sensitivity and glucose tolerance remains limited, according to the study.

Abbott Launches OTC Continuous Glucose Monitor, Lingo

What You Should Know: – Abbott, a global healthcare company, has announced the U.S. availability of Lingo, a continuous glucose monitoring (CGM) system designed for

September 6, 2024

HIPAA & Modern Healthcare Realities: Dispelling Data Sharing Myths

Timi Leslie, President, BluePath Health and Exec Director of the Connecting for Better Health Coalition Myths in healthcare data sharing often cloud the understanding of

July 23, 2024

Quality of snacking matters more than quantity or frequency, study shows

Snacking is becoming increasingly popular, with more than 70% of people reporting they snack at least twice a day.

July 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.